Shots:

• The real-world evidence partnership will allow the Roche to access PicnicHealth’s set of de-identified patient records to gain insights on certain diseases and treatments
• The collaboration will initially focus on MS and may be extended to support Huntington’s disease (HD)- paroxysmal nocturnal hemoglobinuria (PNH)- and hemophilia
• The companies signed a multi-year collaboration that combines over 7yrs. of retrospective medical record data with 5yrs. of prospective data for 5-000 MS patients- including clinical outcomes and MRI images- to explore the progression of the neurodegenerative disease and facilitate the development of personalized treatments

  Ref: Businesswire | Image: Roche